This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fan, Y. Articles by Xu, D. Search for Related Content PubMed PubMed Citation Articles by Fan, Y. Articles by Xu, D.

Differential Expression of Full-length Telomerase Reverse Transcriptase mRNA and Telomerase Activity between Normal and Malignant Renal Tissues

Authors' Affiliations: ¹ Division of Urology, Department of Surgery, ² Department of Oncology-Pathology, and ³ Division of Hematology, Department of Medicine, Karolinska University Hospital, Stockholm, Sweden and ⁴ Department of Urology, Qilu Hospital, ⁵ Institute of Urology, and ⁶ Aging and Health Center, Nursing School, Shandong University, Jinan, PR China

Requests for reprints: Dawei Xu, Hematology Lab, Center for Molecular Medicine, L8:03, Karolinska Hospital, SE-171 76 Stockholm, Sweden. Phone: 46-8-5177-6552; Fax: 46-8-5177-3054; E-mail: Dawei.Xu{at}cmm.ki.se.

Activation of telomerase, a key event during immortalization and malignant transformation, requires expression of the telomerase reverse transcriptase (hTERT). Consistently, lack of telomerase activity and hTERT expression occurs in most normal human somatic cells. However, it has been observed that both normal and cancerous renal tissues express hTERT whereas only the latter exhibits telomerase activity. The mechanism underlying the dissociation between hTERT expression and telomerase activity is unclear. In the present study, we examined telomerase activity and alternative splicing of hTERT transcripts in renal cell carcinoma (RCC) specimens and adjacent normal tissues from 33 patients with RCC. Telomerase activity was detectable in 27 of 33 (82%) RCC samples but none in their normal counterparts. Thirty-two of 33 tumors expressed overall hTERT mRNA and 27 of them contained full-length hTERT transcripts, all with telomerase activity. Although 42% (14 of 33) of normal renal samples expressed hTERT mRNA, none of them had full-length hTERT transcripts, coinciding with lack of telomerase activity. The presence of full-length hTERT mRNA and telomerase activity was significantly associated with c-MYC induction. In tumors, absence of full-length hTERT mRNA or telomerase activity defines a subgroup of nonmetastatic, early-stage RCCs. Taken together, telomerase repression in normal renal tissues is attributed to the absence of full-length hTERT transcripts, whereas telomerase activation is achieved via induction of or switch to expression of full-length hTERT mRNA during the oncogenic process of kidneys, and associated with aggressive RCCs.

Key Words: Alternative splicing • c-MYC • hTERT • RCC • Telomerase

This article has been cited by other articles:

				F. Lou, X. Chen, M. Jalink, Q. Zhu, N. Ge, S. Zhao, X. Fang, Y. Fan, M. Bjorkholm, Z. Liu, et al. The Opposing Effect of Hypoxia-Inducible Factor-2{alpha} on Expression of Telomerase Reverse Transcriptase Mol. Cancer Res., August 1, 2007; 5(8): 793 - 800. [Abstract] [Full Text] [PDF]